Being Alive/Los Angeles; Being Alive Newsletter - November 1993
presented by Mark Katz, MD and reported by Jim Stoecker
The Upjohn antiviral is in the same class as two other recently developed drugs, nevirapine and pyridinone. This class of antivirals is unfortunately known to quickly develop resistance when used alone. They appear to work best when used in combination with the other class of RT inhibitors.
Test tube studies have shown ateviridine's effectiveness against a number of viral strains. And, what may be most significant, no virus was resistant to the drug when tried in combination with either AZT or ddI.
A Phase I study of ateviridine is being formed at USC. About 30 participants are sought with CD4 under 500 and no active opportunistic infections. For information, call Novella Quesada at 213.343.8288.
9311
BA931108
Copyright © 1993 - Beings Alive. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. Being Alive, 621 N. San Vicente Blvd., West Hollywood, CA 90069, Tel - 310.289.2551; FAX - 310.289.9866; Email: BeiAlive@aol.com http://www.beingalivela.org/